FNY Partners Fund’s Medovex Corp. Common Stock MDVX Stock Holding History

FNY Partners Fund’s Portfolio MDVX Stock Details MDVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,300	Closed	-$12K	–	1421
2017 Q1	$12K	Buy	+8,300	New	+$10.4K	﹤0.01%	1067

Other funds holding MDVX

MIC

Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

FNY Partners Fund's MDVX Position: Q2 2017 in Review

FNY Partners Fund sold out of Medovex Corp. Common Stock (MDVX) in Q2 2017, closing a stake of 8,300 shares — an estimated $12K sold.

FNY Partners Fund first reported a position in MDVX in Q1 2017 and held it in 1 quarter. The position peaked at $12K in Q1 2017. 9 funds tracked by Wall St. Rank hold MDVX as of Q2 2017.

FNY Partners Fund reported no remaining Medovex Corp. Common Stock position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 8,300 Medovex Corp. Common Stock shares in Q2 2017, an estimated $12K.
FNY Partners Fund first reported a position in Medovex Corp. Common Stock in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Medovex Corp. Common Stock position peaked at $12K in Q1 2017.
9 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.